The Ketogenic Diet Including Breast Milk for Treatment of Infants with Severe Childhood Epilepsy: Feasibility, Safety, and Effectiveness

被引:15
|
作者
Dressler, Anastasia [1 ]
Haefele, Chiara [1 ]
Giordano, Vito [1 ]
Benninger, Franz [2 ]
Trimmel-Schwahofer, Petra [1 ]
Groeppel, Gudrun [1 ]
Samueli, Sharon [1 ]
Feucht, Martha [1 ]
Male, Christoph [1 ]
Repa, Andreas [1 ]
机构
[1] Med Univ Vienna, Dept Pediat & Adolescent Med, Waehringer Guertel 18-20, A-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Child & Adolescent Neuropsychiat, Vienna, Austria
关键词
ketogenic diet; breast milk; infants; epilepsy; beta-hydroxybutyrate; ASSOCIATION;
D O I
10.1089/bfm.2019.0190
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The ketogenic diet (KD) is a high-fat and restricted carbohydrate diet for treating severe childhood epilepsy. In infants, breast milk is usually fully replaced by a ketogenic formula. At our center, mothers are encouraged to include breastfeeding into the KD if still breastfeeding. This retrospective study describes achievement and maintenance of ketosis with or without inclusion of breast milk. Methods: Data were retrieved from a prospective longitudinal database of children treated with KD for epilepsy analyzing infants <1 year of age. The time to achieve clinically relevant ketosis (>= 2 mmol/L beta-hydroxybutyrate) was compared with and without inclusion of breast milk into standard KD. Ketosis, nutritional intakes, effectiveness, adverse effects, and successful continuation of breastfeeding were evaluated. Results: A total of 79 infants were eligible for analysis. In 20% (16), breast milk was included. Infants with breast milk included into the KD achieved relevant ketosis in 47 hours (interquartile range [IQR] 24-95) compared with 41 hours (IQR 22-70; p = 0.779) in infants with standard KD. Beta-hydroxybutyrate at day 2 was 3.1 mmol/L (IQR 0.5-4.9) and 3.8 mmol/L (IQR 2.2-4.9). Infants with breast milk included received higher amounts of carbohydrates at baseline and calories at 3 months. Seizure freedom and adverse effects showed no relevant differences. No infections occurred in infants receiving breast milk. In two infants, KD was initiated with breast-feds after bottle-feeding KD formula. In 31%, breastfeeding was continued after the KD, and in 25%, inclusion of breast milk and breastfeeding was maintained until complete weaning. Before discharge from hospital, the amount of breast milk included was median 90 mL/day (IQR 53-203) equivalent to median 9% (IQR 6-15). Conclusions: Appropriate ketosis was achieved in most infants and maintained within 48 hours. Incorporation of breast milk into KD is feasible, safe, and effective.
引用
收藏
页码:72 / 78
页数:7
相关论文
共 45 条
  • [41] Author response to 'Problems associated with a highly artificial ketogenic diet: Letter to the Editor Re: van der Louw EJTM, Olieman JF, van den Bemt PMLA, et al. "Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study"'
    van der Louw, Elles J.
    Olieman, Joanne F.
    Catsman-Berrevoets, Coriene E.
    Vincent, Arnaud J. P. E.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [42] An Early Feasibility Study to Assess Safety and Effectiveness of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Stenosis (AS)
    Treede, Hendrik
    Baldus, Stephan
    Pasupati, Sanjeevan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B19 - B19
  • [43] Randomized phase II trial of two different nutritional approaches for patients receiving treatment for their advanced pancreatic cancer: initial results of safety and feasibility of the medically supervised ketogenic diet
    Jameson, Gayle S.
    Borazanci, Erkut
    Hanna, Diana L.
    Roberts, Caroline G. P.
    Pelster, Meredith S.
    Frank, Richard C.
    Alistar, Angela T.
    Wiedmeier-Nutor, Julia E.
    Algaze, Sandra D.
    Fell, Brandon
    Hallberg, Sarah J.
    Roe, Denise J.
    Wertheim, Betsy C.
    Cridebring, Derek
    Rabinowitz, Joshua D.
    Gately, Stephen
    Von Hoff, Daniel D.
    Rasco, Drew W.
    CANCER RESEARCH, 2024, 84 (17)
  • [44] Safety and Effectiveness of a 4-Week Diet on Low-Carb Ready-to-Eat Ketogenic Products as Preoperative Care Treatment in Patients Scheduled for Metabolic and Bariatric Surgery
    Santella, Biagio
    Mingo, Monica
    Papp, Alexander
    Rice, Mark
    Chiappetta, Sonja
    Calabrese, Pietro
    Calenda, Fabrizia
    Pilone, Vincenzo
    Schiavo, Luigi
    NUTRIENTS, 2024, 16 (22)
  • [45] Safety, Feasibility, and Short-Term Clinical Outcomes for Locally Recurrent Breast Cancer Patients Treated With a Second Breast-Conserving Treatment including Intraoperative Radiation Therapy
    Ng, J.
    Khani, J.
    Zhuo, R.
    Trichter, S.
    Nowak, E.
    Smith, M. J.
    Hayes, M. K.
    Swistel, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E32 - E33